Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $44,556,000,000 | reported | |
| FY 2024 | 2024-12-31 | $42,879,000,000 | reported | |
| FY 2023 | 2023-12-31 | $42,857,000,000 | reported | |
| FY 2022 | 2022-12-31 | $44,915,000,000 | reported | |
| FY 2021 | 2021-12-31 | $39,211,000,000 | reported | |
| FY 2020 | 2020-12-31 | $32,218,000,000 | reported | |
| FY 2019 | 2019-12-31 | $25,542,000,000 | reported | |
| FY 2018 | 2018-12-31 | $24,358,000,000 | reported | |
| FY 2017 | 2017-12-31 | $20,918,000,000 | reported | |
| FY 2016 | 2016-12-31 | $18,274,000,000 | reported |
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Twelve months to Jun 27, 2026 · derived
Thermo Fisher Scientific Inc. is the largest of the 11 covered companies the SEC files under this code, by revenue. SIC 3829
Latest filing Sep 29, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $636.00M | $3.00B | $3.64B | $1.72 | 371.48M sh | −1.5% | 57.8% |
| FY2024 | $583.00M | $4.00B | $4.58B |
| $1.56 |
| 377.26M sh |
| −1.1% |
| 63.1% |
| FY2023 | $523.00M | $3.00B | $3.52B | $1.40 | 381.31M sh | −1.1% | 50.9% |
| FY2022 | $455.00M | $3.00B | $3.46B | $1.20 | 385.43M sh | −1.5% | 50.0% |
| FY2021 | $395.00M | $2.00B | $2.40B | $1.04 | 391.19M sh | −0.7% | 35.3% |
8 managers · Quarter ended Sep 30, 2026All holders ›
1